Germany
Breathment, founded in 2020, is a pioneering company headquartered in Germany that is setting out to revolutionize the field of respiratory care. Their innovative approach leverages AI-based software to digitize pulmonary rehabilitation, making it more accessible and efficient for both health professionals and patients. This cutting-edge technology aims to modernize respiratory treatment methods, offering a promising advancement in healthcare solutions.
Recently, Breathment secured a €800.00K seed investment, marking a significant milestone for the company. The funding round attracted notable investors including IP Investment, SCE Freiraum Ventures, Michael Friebe, Alihan Ozbayrak, Meerkat Holding, and Claudia Fell. The influx of capital is poised to enhance their technological capabilities and expand their market reach, presenting a compelling opportunity for investors interested in the intersection of healthcare and technology.
